DCR

multiple myeloma - 1st line (L1) multiple myeloma - 1st line (L1)

versus lenalidomide and dexamethasone
pembrolizumab plus lenalidomide and dexamethasone vs. lenalidomide and dexamethasone 1 certainty unassessable-19%